Can-Fite BioPharma News, Can-Fite BioPharma Quote, CANF Quote

Can-Fite BioPharma (NY:CANF) Delayed: 1.97 +0.01 (0.51%)

Prev. Close

$1.96

Open

$2.00

52 Wk High

$3.89

52 Wk Low

$1.85

Day High

$2.07

Day Low

$1.96

P/E

N/A

EPS

$0.00

Volume

10,459

Friends, Peers and Foes (?): CFBI, KTRA, DYFSF, DYA, BIXT (more...)

Apr 15, 2024 07:04 AM Form 6-K Can-Fite BioPharma Ltd. For: Apr 15
Apr 15, 2024 07:02 AM Can-Fite Bio (CANF) Announces Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Apr 15, 2024 07:00 AM Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Apr 10, 2024 06:03 AM Form EFFECT Can-Fite BioPharma Ltd.
Apr 5, 2024 04:16 PM Form S-8 Can-Fite BioPharma Ltd.
Apr 5, 2024 04:15 PM Form POS AM Can-Fite BioPharma Ltd.
Apr 3, 2024 07:07 AM Form 6-K Can-Fite BioPharma Ltd. For: Apr 03
Apr 3, 2024 07:02 AM Can-Fite BioPharma (CANF) Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Apr 3, 2024 07:00 AM Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients
Mar 28, 2024 09:31 AM Form 20-F Can-Fite BioPharma Ltd. For: Dec 31

Entities mentioned with CANF